Jane Street’s Grace Therapeutics GRCE Stock Holding History

Jane Street’s Portfolio GRCE Stock Details GRCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$774K	Buy	+167,097	New	+$656K	﹤0.01%	7060
2023 Q3	–	Sell	-2,369	Closed	-$7.46K	–	9535
2023 Q2	$7.46K	Buy	+2,369	New	+$7.07K	﹤0.01%	8463
2022 Q1	–	Sell	-3,067	Closed	-$23K	–	11159
2021 Q4	$23K	Sell	3,067 -86	-3%	-$776	﹤0.01%	9767
2021 Q3	$38K	Buy	+3,153	New	+$62.1K	﹤0.01%	9630
2021 Q2	–	Sell	-2,096	Closed	-$60K	–	10541
2021 Q1	$60K	Buy	+2,096	New	+$72.7K	﹤0.01%	8795
2020 Q3	–	Sell	-271	Closed	-$6K	–	8069
2020 Q2	$6K	Buy	+271	New	+$7.9K	﹤0.01%	7001
2016 Q2	–	Sell	-215	Closed	-$16K	–	4697
2016 Q1	$16K	Buy	+215	New	+$16.8K	﹤0.01%	3986
2014 Q3	–	Sell	-62	Closed	-$30K	–	3151
2014 Q2	$30K	Buy	+62	New	+$29.6K	﹤0.01%	2460

Other funds holding GRCE

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return

Jane Street's GRCE Position: Q1 2026 in Review

Jane Street opened a new position in Grace Therapeutics (GRCE) in Q1 2026: 167,097 shares worth $774K. The stake represents ﹤0.01% of the portfolio and ranks #7060 among its holdings. This is a return to the name: Jane Street previously reported a position in GRCE as recently as Q2 2023.

Jane Street first reported a position in GRCE in Q2 2014 and has held it in 8 quarters since. 34 funds tracked by Wall St. Rank hold GRCE as of Q1 2026.

Jane Street held 167,097 shares of Grace Therapeutics worth $774K as of Q1 2026.
Grace Therapeutics was a new Jane Street position in Q1 2026.
Grace Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #7060 holding.
Jane Street first reported a position in Grace Therapeutics in Q2 2014 and has held it in 8 quarters since.
34 funds tracked by Wall St. Rank held Grace Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.